Multisociety Consensus Endorses Beta-Lactam Dose Individualization in Acutely Ill Patients
Seven international societies now formally back concentration-guided beta-lactam dosing, positioning pharmacists to lead TDM and model-informed personalized dosing programs.
📅 Journal publication: Aug 2026·Last updated: Aug 5, 2026
★ Must ReadBeta-Lactam Dose Individualization Consensus GuidanceACCP/ESCMID/IDSA/SCCM/SIDPsepsis and acute illnessbeta-lactam antibioticsTDMMIPDInfectious Disease / Antimicrobials
New guidelines urge personalized beta-lactam dosing for acutely ill patients.
Beta-lactam antibiotics are crucial in treating acutely ill patients, but standard dosing may not ensure optimal efficacy and safety. Consensus guidance recommends individualized beta-lactam dosing based on patient-specific serum concentrations, addressing variability in drug levels. The guideline emphasizes personalized dosing for beta-lactams in severe infections, improving treatment outcomes by tailoring therapy to individual patient needs. Individualizing beta-lactam doses enhances effectiveness and safety for critically ill patients.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Barreto EF, McCreary EK, Pai Mangalore R, Tang Girdwood S, Arriola R, Bens C, Bonomo RA, Edginton AN, Hong LT, Huttner A, Koch BCP, Maranchick N, Neely MN, Peloquin CR, Rao GG, Roberts JA, Röhr AC, Scheetz MH, Schuetz AN, Yarnold PR, Zuluaga A, Rhodes NJ
Citation:Barreto EF, McCreary EK, Pai Mangalore R, et al. Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2026;46(8):e70181. doi:10.1002/phar.70181